Clinical trial
Post-Polio Syndrome Treated With Intravenous Immunoglobulin (IvIg)
NCT00231439 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Polio Syndrome Treated With Intravenous Immunoglobulin (IvIg)
- Lead sponsor
- Haukeland University Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 31, 2003
- Completion date
- July 31, 2004
- Enrollment
- 40
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
post-polio syndrome